Logo

• Closed gynecological cancer (KGOG4002)

  GYANT: Characteristics of GYnecological surgery using Articulated laparoscopic iNsTruments

  • PI / PI기관 Ki Dong Kim /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 400 person / 400 person (100.0%)

• Closed gynecological cancer (KGOG4001)

  A Randomized, Exploratory, Superiority, Investigator Clinical Study Effect of Barbed Suture Fascia Closure on Incisional hernia in Midline Laparotomy for Gynecological Diseases (BARBHER)

  • PI / PI기관 Ki Dong Kim /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 174 person / 174 person (100.0%)

• Closed gynecological cancer (KGOG3045)

  An uMbrella study of BIomarker-driven Targeted therapy In patients with platinum-resistant recurrent OvariaN cancer(AMBITION)

  • PI / PI기관 Jung-Yun Lee /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 91 person / 91 person (100.0%)

• Closed gynecological cancer (KGOG3039)

  SUNNY: Study of Upfront surgery versus Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery for Patients with Stage IIIC and IV Ovarian Cancer

  • PI / PI기관 Jae-Weon Kim /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 489 person / 488 person (100.2%)

• Closed gynecological cancer (KGOG3027)

  ICON8: An international Phase III randomised trial of dose-fractionated chemotherapy compared to standard three-weekly chemotherapy, following immediate primary surgery or as part of delayed primary surgery, for women with newly diagnosed epithelial ovarian cancer

  • PI / PI기관 Jae-Weon Kim /
  • Registration Date / Last Update Posted 2022-05-10 / 2022-05-10
  • Current Enrollment / Estimated Enrollment 1489 person / 1485 person (100.29999999999998%)

• Closed gynecological cancer (KGOG3026)

  GOTIC-001/JGOG3019iPocc: A randomized phase II/III trial of intravenous (IV) paclitaxel weekly plus IV carboplatin once every 3 weeks versus IV paclitaxel weekly plus intraperitoneal (IP) carboplatin once every 3 weeks in women with epithelial ovarian, fallopian tube or primary peritoneal cancer

  • PI / PI기관 Sang-Young Ryu /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 555 person / 654 person (84.89999999999999%)

• Closed gynecological cancer (KGOG3020)

  GOG-213: A phase III randomized controlled clinical trial of carboplatin & paclitaxel alone or in combination with bevacizumab followed by bevacizumab & secondary cytoreductive surgery in platinum-sensitive, recurrent ovarian, peritoneal primary & fallopian tube cancer

  • PI / PI기관 Jae-Weon Kim /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 1050 person / 1052 person (99.8%)

• Closed gynecological cancer (KGOG3019)

  Prospective Multicenter Case-Control Study for Korean Epithelial Ovarian Cancer

  • PI / PI기관 Byoung-Gie Kim /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 1424 person / 3600 person (39.6%)

• Closed gynecological cancer (KGOG3004S)

  The safety of fertility sparing management in advanced malignant ovarian germ cell tumor

  • PI / PI기관 Jeong Yeol Park /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 0 person / 0 person (0.0%)

• Closed gynecological cancer (KGOG3003S2)

  The role of adjuvant chemotherapy in stage 1 malignant ovarian germ cell tumor

  • PI / PI기관 Jeong Yeol Park /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 0 person / 0 person (0.0%)

* (사)대한부인종양연구회는 게시된 세부 임상연구 정보에 대해 법적 책임이 없습니다.